FORT
MYERS, Fla., April 24,
2024 /PRNewswire/ -- The Industrial Technology
Research Institute (ITRI) triumphed at the recent Edison Awards™ in
Fort Myers, Florida, securing
recognition for four exceptional technological breakthroughs: the
Novel Dual-Targeted Therapy for Glaucoma, Key Functional
Cell Identity (KFCI), PureTex Sustainable Decolorization
Solution, and the High Resolution Full-Color Micro LED
Display. Out of 400 nominees, ITRI garnered one gold and three
silver awards, the third-highest number of wins among the global
contenders. This extends ITRI's winning streak at the Edison
Awards™ to eight consecutive years, placing it alongside industry
giants like Dow, Corning, and DuPont.
Upon recognizing ITRI's achievements this year, Executive
Director of the Edison AwardsTM Frank Bonafilia said, "You take not just the
product that you're looking at, but you're looking at the entire
process and how it fits within the supply chain, how it's making
people's lives better. ITRI is consistently innovating
game-changing new products for the last eight years. We couldn't be
happier for your attendance this year as well." He then highlighted
the Novel Dual-Targeted Therapy for Glaucoma, the gold medal
winner: "We lose our sight, and we lose who we are. So that's very
important as well. I really appreciated that product. It's a game
changer."
ITRI President Edwin Liu
expressed his pride in the Institute's accomplishments,
highlighting their commitment to market-driven development: "Our
winning innovations this year address critical sectors like
biomedicine, textiles, and displays, all poised for real-world
impact. For example, KFCI and the glaucoma treatment have been
transferred to Taiwanese biotech companies for further clinical
trials. PureTex is currently undergoing extensive
industry-wide validation for its potential in textile recycling,
while the Micro LED display is being validated across various
industries." "Winning international honors such as this truly
motivates us at ITRI. We will relentlessly continue our work in
empowering industry through innovation," added Liu.
ITRI's Winning Innovations:
The Novel Dual-Targeted Therapy for Glaucoma is the
world's first dual-target glaucoma treatment. Compared to current
glaucoma medications, this eye-drop formulation achieves greater
and more sustainable reductions of intraocular pressure by
simultaneously inhibiting two key enzymes. It requires only one
daily application, reducing side effects such as irritation and
inflammation. Developed by TheratOcular Biotek and licensed to
Metagone Biotech, this medication holds patents in the United States, the European Union, and
Taiwan. This innovation marked
Taiwan's first Edison gold victory
for ophthalmic innovations in the health, medicine, and biotech
category.
Key Functional Cell Identity (KFCI) identifies
super-donor cells before clinical trials start, accelerating the
development and production of cell therapy. KFCI reduces costs by
up to 90% via filtering out ineffective samples and creates an
allogenic stem-cell bank for over 40 different medical conditions,
including diabetes and myocardial infarction. This platform is
capable of mass-producing high-quality cells to generate
100,000–500,000 doses of therapeutic products from one donor. It
has been licensed to biotechnology companies such as Reliance
Medical Technology Corporation for clinical trials. It is a
silver-winning technology in the health, medicine, and biotech
category at the Edison Awards.
PureTex Sustainable Decolorization Solution is an
eco-friendly solution that paves the way for closed-loop textile
recycling by effectively decoloring recycled textiles to their
original colors in 2–4 hours. PureTex increases the reusability of
recycled fibers and reduces up to 45% of carbon emissions. The
operation temperature is approximately 90°C with over 95% dye
removal efficiency. Without the need for facility updates, it's
conducive to large-scale deployment. It has been recognized with a
silver award in the water treatment & testing category at the
Edison Awards.
The High Resolution Full-Color Micro LED
Display is an ultra-high-resolution display technology that
caters to the surging demand for next-gen display technologies. It
outperforms alternatives by offering a resolution of 6700 PPI that
meets near-eye display requirements, more than 10 times the
brightness of its alternatives, and consumes only half the energy
of conventional smart glasses. These make it ideal for applications
like signage, transparent displays, augmented reality/mixed reality
wearables, and automotive dashboards. It won a silver award in the
engineering & robotics category at the Edison Awards.
Visit here to see the complete 2024 winner list.
About ITRI
Industrial Technology Research Institute (ITRI) is one of the
world's leading technology R&D institutions aiming to innovate
a better future for society. Founded in 1973, ITRI has played a
vital role in transforming Taiwan's industries from labor-intensive into
innovation-driven. To address market needs and global trends, it
has launched its 2035 Technology Strategy and Roadmap that focuses
on innovation development in Smart Living, Quality Health,
Sustainable Environment, and Resilient Society.
Over the years, ITRI has been dedicated to incubating startups
and spinoffs, including well-known names such as UMC and TSMC. In
addition to its headquarters in Taiwan, ITRI has branch offices in the U.S.,
Europe, and Japan in an effort to extend its R&D scope
and promote international cooperation across the globe. For more
information, please visit https://www.itri.org/eng.
Media Contact
Alex
Chang
Office of Marketing Communications, ITRI
+886-3-591-8165
changAC@itri.org.tw
View original content to download
multimedia:https://www.prnewswire.com/news-releases/itri-sweeps-2024-edison-awards-with-four-groundbreaking-innovations-302125892.html
SOURCE Industrial Technology Research Institute